click below
click below
Normal Size Small Size show me how
UTA NURS 3261 Exam 2
UTA NURS 3261 Older Adults Exam 2
Question | Answer |
---|---|
Restraint risks | hyperthermia, new-onset bowel and bladder incontinence, constipation, decreased appetite, pressure ulcers, muscle weakness, injury to nerves and joints, or increased risk of nosocomial infections, such as pneumonia and respiratory complications. |
Percent of care provided by families in the US | 80 percent |
Profile of the average, informal caregiver in the US | 46 years old, female, holds a full-time job and spends an average of 18 hours a week caring for her mom who lives nearby. |
Stages of caregiver burnout | 1. Frustration, 2. Isolation, 3. Despair |
Syptoms of caregiver burnout | changes in eating patterns, losing or gaining weight, irritability, impatience, and the inability to multitask. |
Physical abuse | acts of violence that may result in pain or injury, includes sexual |
Signs of abuse | unexplained fractures, welts, burns, ligature marks, unexplained STDs |
Physical neglect | withholding food, water, medications, hygiene, or other goods or services that are necessary for optimal functioning. |
Psychological or emotional abuse | diminishes the identity, dignity, and self worth of the person |
Financial or material abuse | when the older person’s money or property is used for financial gain by the caregiver |
The Social Security Act of 1935 was designed to | prevent destitution among the elderly and dependency on younger workers. |
Part A pays for | hospitalization, home health, hospice and some skilled nursing care. |
Medicare Part B pays for | office visits and outpatient services as well as other things. |
Medicare Part D pays for | prescription drugs |
Medicaid helps pay for | medications, Medicare premiums and copays, custodial care in nursing homes, as well as certain in-home services through CBA - Community-Based Alternative Care. |
Death-defying societies | refuse to believe that death would take anything away and believe it could be overcome. |
Death-accepting societies | view death as an inevitable and natural part of the life cycle. |
And death-denying societies | refuse to confront death, believe that death is the opposite of living and that it’s not a natural part of human existence. |
Three leading causes of death in adult Americans | cardiovascular disease, cancer, and cerebrovascular disease |
Medicare Hospice benefits pay for | for medications related to the terminal condition, nursing care, medical supervision, and medical equipment needed to treat the terminal condition. |
Drugs that increase risk for falls | antiepileptics, benzodiazepines |
Polypharmacy | Five or more drugs |
Of all available nonsteroidal anti-inflammatory drugs, this drug produces the most CNS adverse effects | Indomethacin (Indocin and Indocin SR) |
Narcotic analgesic that causes more CNS adverse effects, including confusion and hallucinations, more commonly than other narcotic drugs. Additionally, it is a mixed agonist and antagonist. | Pentazocine (Talwin) |
One of the least effective antiemetic drugs, yet it can cause extrapyramidal adverse effects. | Trimethobenzamide (Tigan) |
Most of these drugs are poorly tolerated by elderly patients, since these cause anticholinergic adverse effects, sedation, and weakness. Additionally, their effectiveness at doses tolerated by elderly patients is questionable. | Muscle relaxants and antispasmodics: methocarbamol (Robaxin), carisoprodol (Soma), chlorzoxazone (Paraflex),metaxalone (Skelaxin), cyclobenzaprine (Flexeril), and oxybutynin (Ditropan). Do not consider the extended-release Ditropan XL. |
This benzodiazepine hypnotic has an extremely long half-life in elderly patients (often days), producing prolonged sedation and increasing the incidence of falls and fracture. Mediumor short-acting benzodiazepines are preferable. | Flurazepam (Dalmane) |
Because of its strong anticholinergic and sedation properties, this is rarely the antidepressant of choice for elderly patients. | Amitriptyline (Elavil), chlordiazepoxide-amitriptyline (Limbitrol), and perphenazine-amitriptyline (Triavil) |
Because of its strong anticholinergic and sedating properties, this is rarely the antidepressant of choice for elderly patients. | Doxepin (Sinequan) |
This is a highly addictive and sedating anxiolytic. Those using it for prolonged periods may become addicted and may need to be withdrawn slowly. | Meprobamate (Miltown and Equanil) |
These drugs have a long half-life in elderly patients (often several days), producing prolonged sedation and increasing the risk of falls and fractures. | Long-acting benzodiazepines: chlordiazepoxide (Librium), chlordiazepoxide-amitriptyline (Limbitrol) clidinium-chlordiazepoxide (Librax), diazepam (Valium), quazepam (Doral), halazepam (Paxipam), and chlorazepate (Tranxene) |
Of all antiarrhythmic drugs, this is the most potent negative inotrope and therefore may induce heart failure in elderly patients. It is also strongly anticholinergic. Other antiarrhythmic drugs should be used. | Disopyramide (Norpace and Norpace CR) |
May cause bradycardia and exacerbate depression in elderly patients. | Methyldopa (Aldomet) and methyldopa-hydrochlorothiazide (Aldoril) |
May induce depression, impotence, sedation, and orthostatic hypotension. | Reserpine at doses >0.25 mg |
It has a prolonged half-life in elderly patients and could cause prolonged hypoglycemia. Additionally, it is the only oral hypoglycemic agent that causes SIADH. | Chlorpropamide (Diabinese) |
Drugs are highly anticholinergic and have uncertain effectiveness. These drugs should be avoided (especially for long-term use). | Gastrointestinal antispasmodic drugs: dicyclomine (Bentyl), hyoscyamine (Levsin and Levsinex), propantheline (Pro-Banthine), belladonna alkaloids (Donnatal and others), and clidinium-chlordiazepoxide (Librax) |
May have potent anticholinergic properties. | Anticholinergics and antihistamines: chlorpheniramine (Chlor-Trimeton), diphenhydramine (Benadryl), hydroxyzine (Vistaril and Atarax), cyproheptadine (Periactin), promethazine (Phenergan), tripelennamine, dexchlorpheniramine (Polaramine) |
May cause confusion and sedation. Should not be used as a hypnotic, and when used to treat emergency allergic reactions, it should be used in the smallest possible dose. | Diphenhydramine (Benadryl) |
Have not been shown to be effective in the doses studied. | Ergot mesyloids (Hydergine) and cyclandelate (Cyclospasmol) |
Doses >325 mg/d do not dramatically increase the amount absorbed but greatly increase the incidence of constipation. | Ferrous sulfate >325 mg/d |
Are highly addictive and cause more adverse effects than most sedative or hypnotic drugs in elderly patients. | All barbiturates (except phenobarbital) except when used to control seizures |
Not an effective oral analgesic in doses commonly used. May cause confusion and has many disadvantages to other narcotic drugs. | Meperidine (Demerol) |
Has been shown to be no better than aspirin in preventing clotting and may be considerably more toxic. Safer, more effective alternatives exist. | Ticlopidine (Ticlid) |
Immediate and long-term use should be avoided in older persons, since a significant number have asymptomatic GI pathologic conditions. | Ketorolac (Toradol) |
These drugs have potential for causing dependence, hypertension, angina, and myocardial infarction. | Amphetamines and anorexic agents |
Have the potential to produce GI bleeding, renal failure, high blood pressure, and heart failure. | Long-term use of full-dosage, longer half-life, non–COX-selective NSAIDs: naproxen (Naprosyn, Avaprox, and Aleve), oxaprozin (Daypro), and piroxicam (Feldene) |
Long half-life of drug and risk of producing excessive CNS stimulation, sleep disturbances, and increasing agitation. Safer alternatives exist. | Daily fluoxetine (Prozac) |
May exacerbate bowel dysfunction. | Long-term use of stimulant laxatives: bisacodyl (Dulcolax), cascara sagrada, and Neoloid except in the presence of opiate analgesic use |
Associated with QT interval problems and risk of provoking torsades de pointes. Lack of efficacy in older adults. | Amiodarone (Cordarone) |
Causes more sedation and anticholinergic adverse effects than safer alternatives. | Orphenadrine (Norflex) |
May cause orthostatic hypotension. | Guanethidine (Ismelin), Guanadrel (Hylorel) |
Potential for renal impairment. Safer alternatives available. | Nitrofurantoin (Macrodantin) |
Potential for hypotension, dry mouth, and urinary problems. | Doxazosin (Cardura) |
Potential for prostatic hypertrophy and cardiac problems. | Methyltestosterone (Android, Virilon, and Testrad) |
Greater potential for CNS and extrapyramidal adverse effects. | Thioridazine (Mellaril), Mesoridazine (Serentil) |
Potential for hypotension and constipation. | Short acting nifedipine (Procardia and Adalat) |
Potential for orthostatic hypotension and CNS adverse effects. | Clonidine (Catapres) |
Potential for aspiration and adverse effects. Safer alternatives available. | Mineral oil |
CNS adverse effects including confusion. | Cimetidine (Tagamet) |
Potential for hypertension and fluid imbalances. Safer alternatives available. | Ethacrynic acid (Edecrin) |
Concerns about cardiac effects. Safer alternatives available. | Desiccated thyroid |
CNS stimulant adverse effects. | Amphetamines (excluding methylphenidate hydrochloride and anorexics) |
Evidence of the carcinogenic (breast and endometrial cancer) potential of these agents and lack of cardioprotective effect in older women. | Estrogens only (oral) |
Four issues affecting the health of older persons | lack of resources; scarcity of providers; financial barriers; and cultural barriers and biases |